Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × ipatasertib × Clear all

NCT05498896 2025-03-10

BARBICAN

Phase 2 Active not recruiting

Triple Negative Breast Neoplasms

NCT04464174 2024-07-26

PATHFINDER

Phase 2 Completed

Triple Negative Breast Neoplasms